Buprenorphine and Integrated HIV Care Evaluation

NCT00124358 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1350

Enrollment

OTHER

Sponsor class

Conditions

Opioid-Related Disorders
HIV Infections
AIDS

Interventions

DRUG: Buprenorphine
BEHAVIORAL: Integrated HIV care and office-based opioid dependence treatment

Sponsor

The New York Academy of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]